By A Mystery Man Writer
Dana-Farber Cancer Institute researcher details promise, peril of CAR T-cell therapy, which enlists body’s immune system to fight disease.
Despite FDA concern, risk that CAR-T causes cancer appears low
Regeneron hit with FDA rejection for blood cancer therapy - Clinical Trials Arena
First Child to Receive Revolutionary CAR T Therapy Celebrates 10 Years Cancer Free
Myeloma News - Oncology/Hematology
News and Opinions - World Stem Cell Summit
ICancer Event
Archives — Page 5 of 875 — Harvard Gazette
FDA investigating risk of secondary cancers after CAR-T therapy to treat cancer
How serious is FDA warning about revolutionary blood-cancer treatment?— Harvard Gazette
Lyfgenia and Casgevy Become First FDA-Approved Gene Therapies for Sickle Cell Disease - Xtalks
Eric Smith (@ESmithMDPhD) / X
FDA moves closer to sickle cell cure that uses gene editing
The Cancer Revolution: A Groundbreaking Program to Reverse and Prevent Cancer: Connealy, Leigh Erin: 9780738218458: : Books
DDC, Free Full-Text